Download
HTML Embed
HTML EMBED
Click to Copy
Marketplace

The GM strike marches on

Sep 20, 2019

Latest Episodes

Download
HTML Embed
HTML EMBED
Click to Copy
Marketplace Morning Report
Download
HTML Embed
HTML EMBED
Click to Copy
Download
HTML Embed
HTML EMBED
Click to Copy
Marketplace Morning Report
Download
HTML Embed
HTML EMBED
Click to Copy
Download
HTML Embed
HTML EMBED
Click to Copy
Download
HTML Embed
HTML EMBED
Click to Copy
This Is Uncomfortable
Download
HTML Embed
HTML EMBED
Click to Copy
Marketplace Morning Report
Download
HTML Embed
HTML EMBED
Click to Copy
Marketplace Morning Report
Download
HTML Embed
HTML EMBED
Click to Copy
Marketplace Morning Report
Download
HTML Embed
HTML EMBED
Click to Copy

Feds want fewer anti-psychotics prescribed to seniors

Dan Weissmann Mar 2, 2015
Share Now on:
HTML EMBED:
COPY

Some patients with dementia can behave in ways that caregivers find difficult: They hit, they yell. Sometimes, they get prescribed anti-psychotics.

The Food and Drug Administration says that such off-label uses are risky — people taking them are more likely to die.  A new report from the Government Accountability Office recommends steps for reducing their use.

Marketing efforts for these non-approved uses have drawn fire from federal prosecutors. In 2013, Johnson & Johnson paid more than a billion dollars in federal fines for improperly marketing its anti-psychotic drug Risperdal. In March of this year, a Chicago psychiatrist pleaded guilty to accepting $600,000 in kickbacks from another drug-maker.

Not all adoption is illicit, says Dan Mendolson, CEO of Avalere, a health-care consultancy.

“A lot of the demand is driven by the patients’ families,” he says. “These are effective drugs, and the reason why they’re so widely prescribed is because they work beautifully.”

However, they may eclipse other, safer alternatives, says Caleb Alexander, co-director of the Center for Drug Safety and Effectiveness at Johns Hopkins University.

“There are certainly some settings where clinicians and patients and family members are between a rock and a hard place,” Alexander says. “But I don’t think it’s fair to say that there aren’t other options. And I don’t think it’s fair to say that patients are breaking down the doors, trying to access these therapies.”

The Department of Health and Human Services has been attempting to reduce the use of these drugs in nursing homes. Today’s report looks at their use with patients in other settings.

If you’re a member of your local public radio station, we thank you — because your support helps those stations keep programs like Marketplace on the air.  But for Marketplace to continue to grow, we need additional investment from those who care most about what we do: superfans like you.

Your donation — as little as $5 — helps us create more content that matters to you and your community, and to reach more people where they are – whether that’s radio, podcasts or online.

When you contribute directly to Marketplace, you become a partner in that mission: someone who understands that when we all get smarter, everybody wins.